We investigated the expression of HLXB9 in acute myeloid leukemia (AML) and Acute lymphoblastic leukemia (ALL) by taking advantage of the available data from The Cancer Genome Atlas (TCGA), and the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative. This evidence concerns the gene MNX1 and acute lymphoblastic leukemia.